• Mashup Score: 2

    The prevalence of cardiogenic shock (CS) is high and involves approximately 1 in every 6 patients admitted to the cardiac intensive care unit. Despite the introduction of acute mechanical circulatory support (AMCS) and the institution of “shock teams,” in-hospital mortality for patients with CS remains between 30% and 40%.1 A striking paradox in the management of this critically ill population is…

    Tweet Tweets with this article
    • Global CV Forum / Management of Cardiogenic Shock: Present and Future | @DiakosNikos @Texas_Heart | #THIJournal https://t.co/iETMnLrojN https://t.co/YqTPDiK9L0

  • Mashup Score: 0

    Cardiac resynchronization therapy (CRT) is an established therapy for medically refractory heart failure (HF), with a reduction in hospitalization and mortality in addition to improved cardiac function and functional capacity shown in landmark clinical trials.1,2 Cardiac resynchronization therapy is also indicated for patients with systolic dysfunction requiring frequent ventricular pacing (>40%)…

    Tweet Tweets with this article
    • Global CV Forum / Conduction System Pacing for Cardiac Resynchronization Therapy: The 31-Million-Dollar Question | Jitae A Kim @MihailChelu @BCMHouston @Texas_Heart | #THIJournal https://t.co/d0tGfIvRWg https://t.co/hgR9MPaary

  • Mashup Score: 0

    Abstract. Left ventricular assist devices (LVADs) are increasingly used to treat patients with end-stage heart failure. Implantable LVADs were initially developed in the 1960s and 1970s. Because of technological constraints, early LVADs had limited durability (eg, membrane or valve failure) and poor biocompatibility (eg, driveline infections and high rates of hemolysis caused by high shear…

    Tweet Tweets with this article
    • The evolution of durable, implantable axial-flow rotary blood pumps | #THIPubs #YaxinWangPhD #DrOHFrazier | @Texas_Heart #THIJournal https://t.co/HiRkgS5yxr

  • Mashup Score: 0

    Abstract. A 21-year-old man with sensorineural hearing loss and glaucoma presented with severely limited exercise capacity since childhood. He was found to have biventricular concentric hypertrophy with greatest wall thickening at the posterior and lateral walls of the left ventricle apex (1.7 cm) and the free wall of the right ventricle (1.1 cm). There was no inducible left ventricular outflow…

    Tweet Tweets with this article
    • Pathogenic BCS1L Mutation Resulting in Hypertrophic Cardiomyopathy: A Unique Presentation of Nuclear Mitochondrial Disease | Cameron Incognito @JS_HedleyMD Kristine Posadas @XianglingWang @DesaiMilindY @ClevelandClinic | #THIJournal https://t.co/3u2vDTZUH8 https://t.co/dmaCsSOiYy

  • Mashup Score: 1

    Cardiac resynchronization therapy (CRT) is an established therapy for medically refractory heart failure (HF), with a reduction in hospitalization and mortality in addition to improved cardiac function and functional capacity shown in landmark clinical trials.1,2 Cardiac resynchronization therapy is also indicated for patients with systolic dysfunction requiring frequent ventricular pacing (>40%)…

    Tweet Tweets with this article
    • Conduction system pacing for cardiac resynchronization therapy: The 31-million-dollar question | #THIPubs @MihailChelu | @Texas_Heart #THIJournal https://t.co/d0tGfIvRWg